Home > Insider Trading > Filing (0001127602-23-018775)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
882796	Biocryst Pharmaceuticals Inc	BCRX	Biological Products, (No Disgnostic Substances) (2836)	621413174

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1379222	J Nancy Hutson	64 Montauk Avenue Stonington CT 06378		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-06-13	16,745	$0.00	94,684	No	4	A	Direct
Common Stock	Disposition	2023-06-14	12,866	$8.04	81,818	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Automatic Stock Option Grant	Acquisiton	2023-06-13	39,072	$0.00	39,072	$8.18

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
39,072	2024-06-13	2033-06-13	No	4	A	Direct

Footnotes

Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (the "Director Compensation Policy"), which will vest on the first anniversary of the date of grant.
The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $7.89 to $8.12. The reporting person will provide to the issuer, or any security holder of the issuer, or the SEC staff upon request, full information regarding the number of shares purchased at each price within the range set forth in the footnote.
Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy.